Free Review Articles on Aromatase                                 Metatextbook

Freie Reviews über Aromatase                                 Look here for Journal Homepages

  • Aromatase
  • Growth retardation
  • Gynecomastia
  • Puberty (BASKET)
  • 17 beta hydroxysteroid dehydrogenase
  • 21 hydroxylase deficiency
  • Androgen insensitivity syndrome
  • Receptor (Estrogen)
  • Receptor (FSH)
  • Receptor (GnRH)
  • Leptin
  • Adrenal gland (Hyperplasia congenital)
  • StAR
  • McCune Albright s syndrome
  • Kallmann s syndrome
  • 5 alpha Reductase
  • Puberty (Precocious)
  • Congenital adrenal hyperplasia
  • KAL
  • Pituitary gland (Insufficiency Panhypopituitarism)
  • PROP1
  • Puberty (Delayed)
  • LH
  • Receptor (LH)
  • SF1
  • 3 beta hydroxysteroid dehydrogenase2
  • 17 alpha hydroxylase 17 20 lyase
  • Receptor (Androgen)
  • DAX1 NR0B1
  • PC1
  • 17 20 Desmolase
  • 20 22 Desmolase
  • HSD17B3
  • 11 hydoxylase
  • Receptor (Glucocorticoid)
  • GS alpha
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12005Regulation of aromatase expression in estrogen-responsive breast and uterine disease: from bench to treatment.



    		+-nlPharmacol Rev 57(3):359-83 (2005) Bulun SE
    22002Aromatase and its inhibitors: significance for breast cancer therapy.



    		+-nlRecent Prog Horm Res 57(-):317-38 (2002)
    32008Practical guidance for the management of aromatase inhibitor-associated bone loss.



    		+-nlAnn Oncol 19(8):1407-16 (2008) Hadji P
    42005Aromatase inhibition: translation into a successful therapeutic approach.



    		+-nlClin Cancer Res 11(8):2809-21 (2005) Geisler J
    52003Clinical differences among the aromatase inhibitors.



    		+-nlClin Cancer Res 9(1 Pt 2):473S-9S (2003) Ligibel JA
    62003Pharmacology and pharmacokinetics of the newer generation aromatase inhibitors.



    		+-nlClin Cancer Res 9(1 Pt 2):468S-72S (2003) Buzdar AU
    72001Advances in aromatase inhibition: clinical efficacy and tolerability in the treatment of breast cancer.



    		+-nlClin Cancer Res 7(9):2620-35 (2001)
    82008Aromatase inhibitors: are there differences between steroidal and nonsteroidal aromatase inhibitors and do they matter?



    		+-nlOncologist 13(8):829-37 (2008) Miller WR
    92006Appraising adjuvant aromatase inhibitor therapy.



    		+-nlOncologist 11(10):1058-69 (2006) Perez EA
    102001Minireview: aromatase and the regulation of estrogen biosynthesis--some new perspectives.



    		+-nlEndocrinology 142(11):4589-94 (2001)
    112008Use of aromatase inhibitors in children and adolescents with disorders of growth and adolescent development.



    		+-nlPediatrics 121(4):e975-83 (2008)
    122002Clinical review 148: Monogenic disorders of puberty.



    		+-nlJ Clin Endocrinol Metab 87(6):2481-94 (2002)
    132009History of aromatase: saga of an important biological mediator and therapeutic target.



    		+-nlEndocr Rev 30(4):343-75 (2009)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.